CGA
RDY icon

Channing Global Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Channing Global Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22,625
Closed -$345K – 57
2024
Q2 		$345K Hold
22,625
– – 0.29% 43
2024
Q1 		$332K Hold
22,625
– – 0.28% 39
2023
Q4 		$315K Sell
22,625
-8,480
-27% -$113K 0.25% 41
2023
Q3 		$416K Sell
31,105
-45,225
-59% -$612K 0.41% 38
2023
Q2 		$963K Hold
76,330
– – 0.97% 25
2023
Q1 		$869K Hold
76,330
– – 0.96% 28
2022
Q4 		$790K Hold
76,330
– – 0.91% 26
2022
Q3 		$799K Hold
76,330
– – 1.02% 27
2022
Q2 		$846K Buy
+76,330
New +$830K 0.91% 28

Other funds holding RDY

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Channing Global Advisors's RDY Position: Q3 2024 in Review

Channing Global Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q3 2024, closing a stake of 22,625 shares — an estimated $345K sold.

Channing Global Advisors first reported a position in RDY in Q2 2022 and held it in 9 quarters. The position peaked at $963K in Q2 2023. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2024.

  • Channing Global Advisors reported no remaining Dr. Reddy's Laboratories position as of Q3 2024 after selling out during the quarter.
  • Channing Global Advisors sold 22,625 Dr. Reddy's Laboratories shares in Q3 2024, an estimated $345K.
  • Channing Global Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2022 and held it in 9 quarters.
  • Channing Global Advisors's Dr. Reddy's Laboratories position peaked at $963K in Q2 2023.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2024.

Based on Channing Global Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.